Caris Life Sciences Valuation as of Last Funding Round
As of 05/11/21, according to PitchBook Data, Inc.
$7.83 billion
Caris Life Sciences Company Overview
Caris Life Sciences is committed to delivering accurate, high-quality, and comprehensive molecular information to cancer patients as well as oncologists in an effort to advance the use of precision medicine. They are of the opinion that a greater understanding of the disease at the cellular level can lead to improved therapeutic choices and breakthroughs.
Caris' Precision Oncology Alliance (POA) is a growing network of renowned cancer centers located all over the world that collaborate to enhance precision oncology and biomarker-driven research. The alliance includes prominent healthcare and research institutions such as Hoag, St. Joseph Health, and Duke Cancer Institute.
Caris Life Sciences Valuation History
Caris Life Sciences Stock Price
The stock price of Caris Life Sciences can be calculated by taking the valuation of the company divided by the number of shares outstanding. Because a private company can issue new shares at any time, we do not know the current number of shares outstanding.
For illustrative purposes, however, assuming Caris Life Sciences has issued 250 million shares, at the estimated UpMarket valuation of $5.87 billion, each share of Caris Life Sciences stock would be worth $23.49.
Buy Caris Life Sciences Stock
If you would like to buy shares in Caris Life Sciences, please provide your information in the form at the top of this page and click the button titled “I want to buy this stock.”
One of our investor relations team members will contact you to discuss Caris Life Sciences stock availability. Note: inquiries are non-binding and shares may only be purchased by accredited investors that meet all eligibility criteria.
UpMarket has offered many similar companies as Pre-IPO investments, including Airbnb, SpaceX, ByteDance, Plaid, Kraken, Databricks, and others. UpMarket also often has funds available that invest in a portfolio of companies potentially including, Caris Life Sciences as well.
UpMarket's mission is to unlock the private markets for individual investors.
We provide access to a range of asset classes and investment strategies that span private equity, hedge funds, crypto, real estate, and other alternative assets.
The problem
Historically, accessing private market investments had these challenges:
A large barrier to entry due to high investment minimums
Time-intensive because sourcing deals is a lot of work even if you’ve got a great network, and
Costly because of investment-related diligence costs, paperwork, and legal fees
The solution
UpMarket works to address these barriers for individual investors by:
Offering lower investment minimums
Sourcing and conducting diligence on opportunities for investors, empowering them to pick and choose from pre-screened opportunities
Making the investment process entirely digital, straightforward, and easy to manage from a single portal
Individuals like you have invested over $120 Million with UpMarket.
UpMarket Investment Curation Process
Upmarket curates and conducts diligence on every investment opportunity we offer.
We review every offering’s strategy, risk management, liquidity management, fees and expenses, valuation methodology, tax matters, as well as the fund’s third-party providers including legal counsel, auditor, administrator, and custodian.
We aim to offer our clients investments from disciplined managers that pursue unique strategies across an array of asset classes.
Our goal is to empower you to build a portfolio that best meets your individual Investment objectives.
Unlock the private markets today, with UpMarket.
Success!
Thank you for your submission.
A professional from our Investor Relations team will be in touch shortly.
